Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 3 Logistic regression analysis of clinico-pathological parameters, and COX-2 status as predictors of response to treatment in ovarian cancer patients

From: Cyclo-oxygenase-2 (Cox-2) expression and resistance to platinum versus platinum/paclitaxel containing chemotherapy in advanced ovarian cancer

Variable* χ2estimate p value
Stage 0.11 0.7
Residual tumor 4.52 0.03
COX-2 status 2.04 0.09
Type of chemotherapy 2.10 0.11
Interaction 1.7 0.17
  1. Response was subgrouped as follows: complete/partial vs no change of disease/progression.
  2. *Variables were subgrouped as follows: stage III vs IV; residual tumor <2 cm vs ≥2 cm; negative vs positive COX-2 status; interaction COX-2 status/type of treatment
Back to article page